CA2415040A1 - An improved process for the preparation of quinolone derivatives - Google Patents

An improved process for the preparation of quinolone derivatives Download PDF

Info

Publication number
CA2415040A1
CA2415040A1 CA002415040A CA2415040A CA2415040A1 CA 2415040 A1 CA2415040 A1 CA 2415040A1 CA 002415040 A CA002415040 A CA 002415040A CA 2415040 A CA2415040 A CA 2415040A CA 2415040 A1 CA2415040 A1 CA 2415040A1
Authority
CA
Canada
Prior art keywords
formula
compound
meanings given
given above
employed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002415040A
Other languages
French (fr)
Inventor
Reddy Muddasani Pulla
Chowdary Nannapaneni Venkaiah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natco Pharma Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/IN2001/000042 external-priority patent/WO2001085692A2/en
Publication of CA2415040A1 publication Critical patent/CA2415040A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to an improved process for the preparation of quinolone drugs of the formula (I), wherein R=C¿1?-C¿6? alkyl, C¿3?-C¿6? cycloalklyl, aryl, substituted aryl, NR?1¿R?2¿=diarylamino, arylalkylamino, C¿1?-C¿6?-dialkylamino, piprazinyl, N or C alkyl (C¿1?-C¿6?) substituted piperazinyl, morpholino, pyrrolidinyl, substituted pyrrolidinyl, aralkyl, substituted aralkyl etc. Some of the compounds falling within the formula (I) are ciprofloxacin, enrofloxin, pefloxacin, etc. These compounds are useful as antibacterial drugs. The process of the present invention for preparation of compound of formula (I) comprises in enhancing the reactivity of the displaceable halogen (X) in the compound of the formula (II) towards various amines of formula (III) wherein R = as defined for compound of formula (I), R?3¿=COOR?6¿ (R?6¿=C¿1?-C¿6? alkyl, aryl, aralkyl), nitrile a carboxamide (-CONR?7¿R?8¿, R?7¿ and R?8¿ = C¿1?-C¿6? alkyl, C¿3?-C¿6? cycloalkyl, aralkyl), X = Cl, Br, F; NR?1¿R?2¿ = as defined above by introducing a nitro group ortho to the displaceable halo group and subsequently removing the nitro group in a conventional manner. The process of the present invention enhances the yield of the compound of the formula (I) and also improves the quality of the prepared compound.

Description

AN IMPROVED PROCESS t=OR THE PREPARATION OL~
QUINOLONE DERIVATIVES.
s The present invention relates to an improved process for the preparation of quinolone derivatives. The present invention particularly relates to an improved process for the preparation of quinolone derivative of the general formula I.

R

wherein R=C~-G6 alkyl, Cs-C6 cycloalkyl, aryl, substituted aryl, Ia NR'R2=diarylamino, arylalkylamino, C~-C~ -dialkylamino, piprazinyl, N or C
alkyl (C~-C6) substituted piperazinyl, morpholino, pyrralidinyl, substituted pyrrolidinyl, aralkyl, substituted aralkyi etc.
The compounds of the general formula I are normally prepared by reacting the zs appropriate haloquinolone of the formula 1l _s_ wherein R = as defined for compound of formula-I, R3=COORS (Rs=C~-Cs alkyl.,.~ryl, aralkyl), nitrite, a carboxamide (-CGJNR~Rs, R7 and R$ = C~-Cs alkyl, C3-Cs cycloalkyl, aralkyl), X= C1, F
with an appropriate amine of the formula Ill R2~fJ-H
R
wherein NR~ R2=diarylamina, arylalkylamino, C~-Cs-dialky(amino, piperazinyl, N
or C
alkyl (C~-Cs) substituted piperazinyl, morpholino, pyrrolidinyl, substituted pyrrolidinyl, m aralkyl, substituted aralkyl, etc.
in a polar erotic or aprotic solvent at a high temperature for a prolonged periad (llS
patent nos. 4,146,719 and 4,670,444). The above said reaction is illustrated as shown in scheme-1 below.

''1~-1 ----~,.
2r R
R
IV
R
wherein R, R~ and R2 are as defined above.
~ChiEME-"~
s For example, Giprofloxacin( I, R - cyclopropyl, NR'R2 - piperazinyB ) and enrofloxacin { I , R = cyclopropyl , NR'R2 = 4 - ethyl- piperazinyl} are prepared in 70 - 75°f° yield by reacting a compound of formula - IV ( R =
cyclapropyl, X = GI} with 4 - 5 equivalents of a compound of formula - III { NR' R2 = piperazine for ciprofloxacin and N - ethyl piperazine for enroflaxacin } in pyridine medium for 6 - 8 ~o hrs. at X20°C (Grohe, et al, Liebigs Ann. Ghern. 1087, 1, ~9- 3T ) Similarly , norfloxacin ( I, R = ethyl, NR'R2 = piperazinyl ) and pefloxacin {
R = ethyl, NR~R2 = 4-methyl- piperazinyl } are prepared in 66 --G8% yield by reacting a compound of formula - IV ( R = ethyl, X = GI ) with 4 - 5 equivalents of a compound of formula - III ( NR~R2 = piperazine for norfloxacin and N - methyl-piperazine for pefloxacin ) with no solvent at 135 - 140°C far 5 hrs. ( Koga,et al, J.
Med. Chem.
1980, 23, 1358 -1363).
s The above said process has the following disadvantages:
1. Selectivity for the halogen displacement i~ only 90 to 95°!°.
The remaining material is a fluorine displaced derivative.
2. The process requires more than 3 motes of the amine per mole of quinotonic acid.
3. The reaction requires very high temperature {more than 120° C) and prolonged to reaction time (4 - 8 hours).
4. Removal of impurity is a tedious process and recovery of the final product is not 100°!°.
5. The yield of the final product is normally less than '~0°!°.
Another conventional process disclosed in PCT International application Wa 88 is 0',993 involves the enhancement of halogen activity by chelating the {i-keto acid part of quinatanic acid of formula IV with a boron derivative B(OAc)3 of the formula {V).
This reaction is shown in the Scheme-2 given below.

~ f ~AC)~, >
m R
Vt R t 'where in X, R, R' and R2 are as defined above s For example, a compound of formula - tV ( R =cyclopropyl, X =GI) is reacted with boric acid triacetate (V) in acetic acid medium to get a compaund of fiormula -Vl ( R
= cyclopropyl, X = CI } in almost quantitative yield. This compound is reacted with 3-4 moles of a compound of formula - III ( NR~R2 = piperazine ) in DMSC7 solvent medium for 10 mins. at 110 - 120°C to get eiprafloxaein { I, R =
cycloprapyt, NR~R2 =
to piperazinyl ) in 95°lo yield.
-s-This process has the following disadvantages:
1. The process requires high temperature (> 100° C) 2. The reaction time is too short (l0minutes) to perform it on a commercial scale.
s 3. The reaction works with only polar aprotic solvents like DMSa.
4. The reaction requires more than 3 moles of amine per mole of quinolonic acid.
5. Though the process claims to have more than 90% yield actually it never exceeds 75%.
to Since the quinofone drugs like ciprofloxacin, enrofloxacin, etc falling within the general formula i given above are very useful broad spectrum antibacterial drugs there is a need to enhance the yield as well as the purity of the said compounds prepared. Accordingly there is an urgent need for developing an improved process for the preparation of the said compounds resulting in higher yields end improved Is purity.
Therefore the main objective of the present invention is to provide an improved process for the preparation of compounds of the general forrnuia ! defined above having improved yield (90 - 9~%) as well as improved purity ( >_99°~).
-f>-Another objective of the present invention is to provide an improved process for the preparation of compounds of the general formula I as defined above by enhancing the reactivity of the halogen (X} in the formula IV given above towards various amines thereby reducing the formation of the impurity of the formula VII, R
VII
s wherein X, R, R~, R2 are as defined above.
resulting in the increased purity of the final compound of the formula I.
lfet another objective of the present invention is to provide an improved process for the preparation of the compound of the formula I defined above which process 1a involves a facile reaction on both of the halogens in the compound of the formula VIII.
R

wherein R, R3 are as defined above.

The invention has been developed based on our finding that:
1, Both the chlorines present in the formula Vlll undergo the reaction even at room s temperature.
2. The low temperature reaction leads to higher yields ( 90 - ~5°!0) and better purity (~ 99°!0) of the compounds of the formula I.
3. The amount of the costly amine of the formula Ili (R'R2NH) in the process requires only one equivalent.
l0 4. The step of removing the impurity of formula VII is totally eliminated as no such impurity is formed.
Accordingly the present invention provides an improved process for the preparation of compound of the general formula I as defined above which comprises:
is i. converting 2,4-dichloro-5-fiuoroacetophenone to 2,4-dichloro-5-fluoro-3 nitrobenzoic acid by conventional methods.
ii, reacting the ° 2,4-dichloro-5-fluoro-3-nitrobenzoic acid with thionyl chloride I
oxalyl chloride to get the corresponding benzoyl chloride.
_g_ iii, reacting the 2,4-dichloro-5-fluoro-3-nitrobenzoyl chloride v~ith the compound of the formula 1X
s R
'NR4R
IX
s wherein R3 = C4t7R6 (R6=C~-C6 alkyl, aryl, aralkyl}, nitrile, and carboxamide (Ct~NR7R8, R7 and R~ = C~-C3 alkyl, cyclo alkyl, aralkyl), R4, R5 = C1'C6 alkyl, aralkyl, cycloalkyl, (Cs-Cs} together with the nitrogen atom to which they are bonded to give a compound of formula-X.
to to yield the corresponding novel acrylate of the formula X.
RR
NQz X
wherein R3, R4 and R~ are as defined above.

iv. reacting the novel compound of the formula X with a primary amine RNH2 (of the fiormula XI) where R is as defined above to give a compound of the formula VIII.
R
N~

s wherein R & R3 have the meanings given above.
v. reacting the compound of the formula VIII with a base in the presence ofi a polar aprotic or nonpolar solvent or their mixtures to give a new compound of the formula XII.
X)I
wherein R, R3 are as defined above.
-lo-vi. reacting the novel quinolone of the formula XII with an amine R~ NHR2 (of the formula Illj, wherein R~ and R2 have the meanings given above to give the corresponding chloro displaced novel product of the formula XIII.

X~I~
s wherein R, R~, R2 & R3 have the meanings given above.
vii. subjecting the compound of the formula Xlil to metal reduction by conventional methods to yield a novel compound of the formula XIlI.
F
XIV
to wherein R, R', R2 & R3 have the meanings given above.

iw2 K
1~8-~ R

viii, deaminating the compound of the formula XIV via its diazonium salt and decomposing the salt by conventional methods to yield fihe compound of the formula I as defined above OR decomposing the diazonium salt of the s compound of the formula XIV in the presence of copper (i) halide to give a novel halide derivative of the formula XV.
wherein R, R', R2 & R3 have the meanings given above, and X = H, GI, Br.
1fl iX. dehalogenating the compound of the formula XV by conventional methods to yield the compound of the formula I as defined above.
In a preferred embodiment of the invention the step (i) above may be carried out following method contained in J. Heterocyclic Chemistry 1988, 28, 927. The nitro Is group present in this acid enhances the reactivity of both the GI atoms in the subsequent steps.

X R
XV

The transamination in step (iv) may be done in routine solvents such as alcohofs like methanol, ethanol, isopropanol, etc; aromatic solvents like benzene, toluene, etc.
The reaction temperature may be in the range of 0 to 60° C. The preferred temperature being in the range of 0 to 25° C.
s The base employed in step (v} may be MOR where M represents Na, K and R
represents C~ to C~. atoms, carbonate salts like FC2CO3, Na~COs, metal hydride like NaH. The polar solvent employed may be selected from DMF, pMSO, DMAc etc and the nonpolar solvent can be benzene, toluene, xylene etc.
The step (ui) may be effected at a temperature in the range of 25 to 100° C, preferably in the range of 25 to 40° C. The medium which can be employed for the reaction may be a polar aprotic solvent such as DMF, DMSO, IPA, n-BuOH, t-BuOH
etc. An aromatic solvent such as benzene, toluene, xylene, a halogenated solvent is like CH2C12 CHC13, and acetonitrile. The reaction may also be conducted with one equivalent of amine and a base like Na2CO3, tf2CO3, NaHCO~, TEA etc.
The deducing agent which may be employed in step (vii) may be Raney nickel, PdIC, FeIAcOH, SnIHGI etc. preferably Raney nickel or PdIC ( 5 to 10°f°). The medium 2o which can be employed may be selected from alcoholic solvent such as methanol, ethanol, isapropanol etc., esters like ethyl acetate. The preferred solvent may be methanol. The temperature employed in the reaction may be in the range of 20 to 100° C, preferably 20 to 40° C. The hydrogen pressure employed may be in the range of 10 to 60 psi preferably 20 to 40 psi.
The deamination step (viii) may be effected via the diazonium salt derived from a s compound of formula XIV which can be decomposed in the presence of alcohol or hypophosphorous acid to give directly the compound of the formula I (XV, X = H
) or it can be decomposed in the presence of copper (1) halide to give the halo derivative of the formula XV.
R~
XV
~o wherein X, R, R~, R2 & R3 have the meanings given above The diazonium salt can be prepared in dil H2~t34 medium for its direct conversion to a compound of the formula I or in dil aq HX where X represents CI or Br medium for its conversion to a compound of the formula XV. The decomposition temperature 1s employed may be in the range of 5 to 80° C preferably 15 to 30° C for direct conversion to the compound of the formula i. For the conversion to the halo derivative of the formula XV, the temperature may be in the range of 20 to 40° C, X R

The halo derivative of the formula XV can be dehalogenated to give the compound of the formula I by any conventional methods. The methods which can be employed may be selected from treating with Raney nickel or Pd/G under hydrogen atmosphere s in the presence of acid scavenger to neutralise the liberalised acid. The catalyst which may be employed for the conversion may be preferably 5% PdIG, The acid scavenger employed may be amines of the general formula R3N where R represents C~ to Cs alkyl, or carbonate or bicarbonate salts of i~a or K, preferably triethylamine.
The temperature of reaction employed may be in the range of 20 to 100°
C preferably l0 20 to 40° G. The hydrogen pressure employed may be in the range of 10 to 60 psi preferably 20 to 40 psi. The solvent medium which can be employed may be selected from methanol, ethanol, isopropanol etc.
The protecting group present on (VH group of NR~R2 may be deprotected by acid or is bash hydrolysis and also R3 (if it is an ester, amide or nitrite) can also be hydrolysed in one operation. The acid employed may be sulphuric acid in combination with water and l or acetic acid. The base employed may be a strong base like NaOH or Kt~H.
The preferred hydrolysis for piperazine type amine with an acyl protection and being an alkyl ester would be dilute sodium hydroxide {2 to 10°!0 or NaOH) at a 2o temperature in the range of 20 to 100° C, preferably at 40 to 80° C.

The invention is described in detail in the Example given below which is provided to illustrate the invention only and therefore it should not be construed to limit the scope of the invention.
s EXAMPLE 1 (i) Preparation of methyl 2-(2,4-dichloro-5-fluoro-3-nitrobenzoyl-3-dimethyl-aminoacrylate of the formula X where NR4Ft~ represents N(GH3)2 & R3 represents C02 Me.

Into a solution of 108 gm of methyl 3-dimethylaminoethylacrylate and 92 gm of triethyl amine in toluene (1500 ml) at 70°C - 80°C was added a solution of 2,4-dichloro-5-fluoro-3-nitrobenzoyl chloride (prepared from 200 gm of the corresponding acid and 100gms of thionyl chloride) in 500 ml of toluene. The is reaction mixture was refluxed for 6h and cooled to room temperature. tNater (1.5 lit.) was added and extracted the title product into toluene. After evaporation of solvent 300 gm of crude title product remained. A small sample can be recrystallized from methanol. MP: 123 -125°C.
20 (ii) Preparation of methyl 2-(2,4-dichloro-5-fluoro-3-nitrobenzoyl)-3-cyclo-propylaminaacrylate of the formula VIII where R represents cylcopropyl & R3 represents C02Me.

A solution of the crude compound prepared in step(i) in methanol (10D0mf}
was treated with cyclopropylamine (54gr) at 0-10°C. After stirring for 2-3 hrs at RT title product was filtered and washed with 200 ml of chilled methanol, to $ give 240.Ogr of title product. MP : 169 - '170°C.
(iii) Preparation of ' methyl 1-cylcopropyl-6-fluoro-7-chloro-8-nitro-1,4-dihydro-4-oxo-3-quinolinecarboxylate of the formula XI! where R represents cyclopropyl & R3 represents Co2Me.
A mixture of 189gr of compound prepared by the process described in step(ii}, 57gr of potassium carbonate and 300 ml of DMF was heated to 60 - 70°C
under stirring: After maintaining far 3 hrs, the reaction mixture was cooled to - 20°C and filtered the solid. Filtered cake was washed with water to is remove all inorganics and finally with 100m1 of methanol to give the title compound. '~P~iefd 170gr. MP : 226 - 228°C.
(iv) Preparation of methyl 1-cyclopropyl-6-fluoro-7-(1-piperazinyl)-8-nitro-1,4-dihydro-4-oxo-3-quinoiinecarboicyiate of the formula Xlil where R represents cyclopropyl, R3 represents C02Me & NR~R2 represents 1-piperazinyl.

A mixture of the compound prepared in step (iii) (50gr), DMSO (150 ml), piperazine (13gr) and NaHGOs (l3gr) was stirred at RT for overnighfi. The reaction mixture was poured into water (400 ml) and filtered the title compound. Yield: 55 gr. MP : 194 - 196°C.
s {v) Preparation of methyl 1-cyclopropyl-S-f(uoro-7-{4-acetyl-1-piperazinyi)-8-nitro-1,4-dihydro-4-oxo-3-quinolinecarboxylate of the formula XII1 where R
represents cyclopropyl R3 represents C02Me & NR'R2 represents 4-acetyl-1-piperazinyi.
A mixture of the compound prepared in step{iv) (33gr), acetic anhydride (70 ml) and methylenechloride {250 ml) was stirred at RT for overnight. The reaction mixture was poured into water and the title product extracted into methylenechloride and evaporation of solvent left the title compound as a light is yellow solid. Yield 35gr. MP : Above 250°C.
(vi) Preparation of methyl 1-cyciopropyl-5-fluaro-7-(4-acetyl-1-piperazinyl)-8-amino-1,4-dihydro-4-oxo-3-quinolinecarbaxylate of the formula XIV where R
represents cyclopropyl, R3 represents C02Me, and NR~R2 represents 4-acetyl-2a 1-piperazinyl.

A mixture of the compound prepared in step(v) (26gr), Raney nickel (25gr) and methanol (500 ml) were taken into an autoclave and shaken at 20-30psi hydrogen pressure for 3-4 hrs. When the absorption of hydrogen ceased, it was filtered and the filtrate concentrated to give the title compound as a white s solid. Yield 22gr. MP: Above 250°C.
(vii) Preparation of methyl 1-cylcopropyi-6-fluoro-7-(4-acetyl-1-piper~zinyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylate of the formula XV where R represents cyclopropyl, R3 represents CtJ2Me, NR~R2 represents 4-acetyl-1-piperazinyl no and X represents hydrogen.
A solution of the oompound prepared in step(vi) (S.Ogr), and 10°!° H2S0ø (25 ml) was cooled to 0-5°C and treated with sodium nitrite (0.96gr) in water (3m1).
After stirring for another 15 min, the diazonium solution was added into 15°!°
15 aq hypaphaspharous acid (50 ml) at 0-5°C. After the addition, reaction mixture was allowed to reach 25°C and maintained overnight. The reaction mixture was poured into ice water (100 ml) and extracted the title product into methylenechloride (2 x 50 ml). Evaporation of solvent gave the title compound. Yield 4.5gr. MP: 245 - 247°C.

(viii) Preparation of 1-cyclopropyl-6-fluoro-7-(1-piperazinyf)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid of formula 1 where R represents cyclopropyl NR~R2 represents 1-piperazinyl (ciprofloxacin).
s The compound prepared in step(vii) (5gr) and aq. sodium hydroxide (2gr in 20 ml water) was heated at 70 - 80°C for 3 hrs. The solution thus obtained was cooled to RT and neutralized with acetic acid to pH 7Ø The precipitated title product was filtered and washed with water to give the title acid in quantitative yield (4.5gr).

Exempts 2.
i) Preparation of methyl 1-cyclopropyi-6-fluoro-7-(4-acetyl-1-piperazinyl)-8-chloro-1,4-dihydro-4-oxo-3-quinolinecarboxylate of the formula XV where R
represents cyclopropyl, R3 represents CC~2Me, NR~R~ represents 4-acetyl-1-Is piperazinyl, and X represents chloro group.
To a stirred suspension of methyl 1-cycfopropyl-6-fluoro-7-{4-acetyl-piperazinyl)-8-amino-1,4-dihydro-4-oxo-3-quinolinecarboxylate {5gr) and cone HCl {25m1) at 0°C was added sodium nitrite (l.Ogr) in water (5m1).
After stirring 2o for 15 min, the diazonium salt was poured into a solution of GuCI (3.0gr) in 25m1 of eonc.HCl. The reaction mixture was stirred at RT for 5 - 6 hours and _20_ diluted with water. Title product formed was filtered and dried to yield the title compound. Yield 5.5gr. MP: 229 - 23(3°C.
ii) Preparation of methyl 1-cylcopropyi-6-fluoro-7-(4-acetyl-1-piperazinyl)-1,4-s dihydro-4-oxo-3-quinolinecarboxylate of the formula XV where R represents cyciopropyl, R3 represents C02Me, NR'R2 represents 4-acetyl-1-piperazinyl and X represents hydrogen.
A solution of the chloro compound prepared in step(i) (8gr) irt methanol lca (200m1) was hydrogenated with Raney nickel (4gr) at 20 - 40psi pressure of hydrogen. After completion of reaction, catalyst was filtered off and the product isolated by removal of solvent. Yield: 7.Ogr. MP: 245 - 247°C.
Example 3 ~s l. Preparation of methyl-1-cyclopropyl-6-fluoro-7-(4-acetyl-1-piperazinyl)-8-bromo-1,4-dihydro-4-oxo-3-quinolinecarboxylate of the formula XV where R
represents cyclopropyl, R3 represents C02Me, NR' R2 represents 4-acetyl-1-piprazinyl, and X represents bromo group.

To a stirred suspension of methyl 1-cyclopropyl-6-fiuaro-7-(4-acetyl-1-piperazinyl)-8-amino-1,4-dihydra-4-oxo-3-quinolinecarboxylate (S.Ogr) and s canc.HBr (25m1) at 0-5°C was added sodium nitrite (1.0gr) in water (5m1). After stirring tar 15-20min, the diazonium bromide was poured into a solution of CuBr (5.0gr) in 25m1 of cone HBr. The reaction mixture was stirred at 25-30°C
for 5hrs and diluted with water. The precipitate formed was filtered and.
dried to yield the title compound. Yield 5.8 gr. M. P.: 240 - 242°C.
ii. Preparation of methyl 1-cycloprapyl-6-fluora-7-(4-acetyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinalinecarbaxylate of the formula XV where R represents cyclopropyl, R3 represents C02Me, NR~R~ represents 4-acetyl-1-piperazinyl and X represents hydrogen.
A solution of the bromacompound prepared in step(i) (5.0gr) in methanol (150mi) was hydrogenated with Raney nickel (2.5gr) at 20-40psi pressure of hydrogen. After completion of reaction, catalyst was filtered off and the product isolated by removal of solvent. Yield;4.1gr. M.P. 245-247°C.
_22_ Example 4 (i) Preparation of methyl 1-cyclopropyl-6-fluaro-7-(4-ethyl-1-piperazinyl)-S-nitro-1,4-dihydro-4-oxo-3-puinolinecarboxylate of the formula XIII where R
s represents cylcopropyl, R3 represents -C02Me, and NR~ Rz represents 4-ethyl piperazinyl groups.
A mixture of methyl 1-cyciopropyl-6-fluoro-7-chloro-8-nitro-1,4-dihydro-4-oxo-3-quinolinecarboxylate (20gr), pMSO {60m1) and N-ethylpiperazine (7gr) was to stirred at RT far overnight. The reaction mixture was poured into water and filtered the light yellow crystalline compound. Yield: 24gr. M.P: 204 -206°G.
(ii) Preparation of methyl 1-cyclopropyl-6-fluoro-7-(4-ethyl-1-piperazinyl)-8-arnina-1,4-dihydro-4-oxo-3-quinoiinecarbaxylate of the formula XiV, where R
~s represents cycloprapyl, R3 represenfis -G02 Me, and NR~R~ represents 4-ethylpiperazinyl groups.
A mixture of the compound prepared in step(I) (20gr), methanol (200m1) and Raney nickel (6gr) was stirred under hydrogen pressure (20 - 30 psi) for 3 - 4 2o hrs and filtered off catalyst. Removal of solvent gave the title compound.
Yield 18gr. M. P.: 236 - 238°C.

(iii) Preparation of methyl 1-cyclopropyl-6-fluoro-7-(4-ethyl-1-piperazinyf)-8-bromo-1,4-dihydro-4-oxo-3-quinofinecarboxylate of formula XV where R represents cyclopropyl, R3 represents-CQ2Me, NR~R2 represents 4-ethyl piperazinyl, and X represents bromo group.
s To a stirred suspension of the compound prepared in step(ii) (l0gr) and conc.HBr {50m1) at 0-5°C was added sodium nitrite (2.0gr) in 10m1 of water.
After stirring for 15-20min, the diazonium bromide solution was poured into a solution of copper (l) bromide (B.Ogr) in 40m1 of conc.HBr. The reaction mixture was stirred at RT for overnight and poured into 200m1 of water. After to adjusting the pH of the reaction mass to 7.t~ with solid sodium bicarbonate, title product was isolated by filfration. Yield:11.Ogr. M. P.:205-20G°C.
(iv) Preparation of methyl 1-cyclopropyl-6-fluoro-7-(4-ethyl-1-piperazinyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylate of formula XU, where R represents is cyclopropyl, R3 represents -C02Me, NR~R2 represents 4-ethyl pyperazinyl, and X represents hydrogen groups.
A solution of the abave compound {l0gr) in methanol {100m1) was hydrogenated with Raney nickel (3gr) at 20-40psi to get the title compound as light yellow solid. Yield 9gr. M.P.: 240 - 245°C.

(v) Preparation of 1-cyclapropyl-6-fluoro-7~(4-ethyl-1-piperazinyl)-1,4-dihydra-4-oxo-3-quinoiinecarbaxylic acid of formula l, where R represents cyclopropyl, NR~ R2 represents 4-ethyfpiperazinyl group.
s The above compound (5gr) was hydrolyzed using aq. sodium hydroxide (2gr in 20m1) at 80°C for 3hr and neutralized with acetic acid to get a light yellow solid. Yield 4.~gr. M.P: 219 - 221 °G.
Advantages of the invention i0 1. The process utilises law temperature, which leads to higher yields(90 -99%) and better purity(>_ 99%) of the compounds of the formula t.
2. The amount of the costly amine' of the formula III (R~RZNH) in the process is requires only one equivalent.
3. The step of removing the impurity of formula VII is totally eliminated, as there is no such impurity formation in the process of the present invention.

Claims (30)

We Claim:
1. Novel compound of the formula X

wherein NR4R5 and R3 have the meanings given above
2. Novel compound of the formula VIII

wherein R and R3 have the meanings given above.
3. Novel compound of the formula XII

wherein R and R3 have the meanings given above.
4. Novel compound of the formula XIII

wherein R, R3 and NR1R2 have the meanings given above
5. Novel compound of the formula XIV

wherein R, R3 and NR1R2 have the meanings given above
6. Novel compound of the formula XV

wherein R, R3, NR1R2 and X have the meanings given above
7. An improved process for the preparation of compound of the general formula I as defined above which comprises (i) converting 2,4-dichloro-5-fluoro-acetophenone to 2,4-dichloro-5-fluoro-3-nitrobenzoic acid by conventional methods (ii) reacting the 2,4-dichloro-5-fluoro-3-nitrobenzoyl chloride with the compound of the formula IX

wherein R3, R4 and R5 have the meanings given above to yield the corresponding novel acrylate of the formula X

wherein NR4R5 and R3 have the meanings given above (iii) reacting the novel compound of the formula X with a primary amine RNH2 (of the formula XI) where R is as defined above to give a compound of the formula VIII

wherein R & R3 have the meanings given above (iv) reacting the compound of the formula VIII with a base in the presence of a polar aprotic or nonpolar solvent or their mixtures to give a new compound of the formula XII

wherein R and R3 have the meanings given above (v) reacting the novel quinolone of the formula XII with an amine R1NHR2 (of the formula III) wherein R1 and R2 nave the meanings given above to give the corresponding chloro displaced novel product of the formula XIII

wherein R, R1, R2 & R3 have the meanings given above (vi) subjecting the compound of the formula XIII to metal reduction by conventional methods to yield a novel compound of the formula XIV

wherein R, R1, R2 & R3 have the meanings given above (vii) deaminating the compound of the formula XIV via its diazonium salt and decomposing the salt by conventional methods to yield the compound of the formula I as defined above or decomposing the salt in the presence of copper (I) halide to give a halide derivative of the formula XV

wherein X, R, R1, R2 & R3 have the meanings given above (viii) dehalogenating the compound of the formula XV by conventional methods to yield the compound of the formula I as defined above
8. A process for the preparation of novel compound of the formula X

wherein R3, R4 and R5 lave the meanings given above which comprises:

(i) converting 2,4-dichloro-5-fluoro-acetaphenone to 2,4-dichloro-5-fluoro-3-nitrobenzoic acid by conventional methods and (ii) reacting the 2,4-dichloro-5-fluoro-3-nitrobenzoyl chloride with the compound of the formula IX.

wherein R3, R4 and R5 have the meanings given above
9. A process for the preparation of novel compound of the formula XII

wherein R, R3 have the meanings given above.

which comprises reacting the compound of the formula VIII with a base in the presence of a polar aprotic or nonpolar solvent or their mixtures.
10. A process for the preparation of novel compound of the formula XIII which comprises reacting the novel quinolone of the formula XII with an amine R1NHR2 (of the formula III) wherein R1 and R2 have the meanings given above.
11.A process for the preparation of novel compound of the formula XIV which comprises subjecting the compound of the formula XIII to metal reduction by conventional methods.
12.A process for the preparation of novel compound of the formula XV which comprises decomposing the compound of the formula XIV in the presence of copper (I) halide to give a halide derivative of the formula XV.
13. A process as claimed in claim 1 (step 1) wherein the reaction is carried out following method contained in J. Heterocyclic Chemistry 1988, 25, 927.
14. A process as claimed in claim 1 step iii & claim 9 wherein the trans -amination is done in routine solvents such as alcohols like methanol, ethanol isopropanol etc.
aromatic solvents like benzene, toluene etc. The reaction temperature being in the range of 0°C to 60° C, the preferred temperature being in the range of 0°C to 25°C.
15. A process as claimed in claim 1 step iv & claim 10 wherein the base employed be MOR where M represents Na, K and R represents C1 to C4 atoms, carbonate salts like K2CO3, Na2CO3, metal hydride like NaH.
16. A process as claimed in claim 1 step v and claim 11 wherein the polar solvent employed is selected from DMF, DMSO, DMAc etc and the nonpolar solvent can be benzene, toluene, xylene, etc.
17. A process as claimed in claim 1 step v and claim 11 wherein the reaction is effected at a temperature in the range of 25 to 100° C, preferably in the range of 25 to 40° C.
18. A process as claimed in claim 17 wherein the medium employed for the reaction is a polar aprotic solvent such as DMF, DMSO, IPA n-BuOH, t-BuOH etc. an aromatic solvent such as benzene, toluene, xylene, a halogenated solvent like CH2Cl2, CHCl3, and acetonitrile.
19. A process as claimed in claim 18 wherein the reaction is conducted with one equivalent of amine and a base like Na2CO3, K2GO3, NaHCO3, TEA, etc.
20. A process as claimed in claim 1 step vi & claim 12 wherein the reducing agent employed is selected from Raney nickel, Pd/C Fe/AcOH, Sn/HCI etc. preferably Raney nickel or Pd/C (5 to 10%).
21. A process as claimed in claim 20 wherein the medium employed is selected from alcoholic solvent such as methanol, ethanol, isopropanol etc. esters like ethyl acetate, the preferred solvent being methanol.
22.A process as claimed in claim 21 wherein the temperature employed in the reaction is in the range of 20 to 100° C, preferably 20 to 40°
C, the hydrogen pressure employed being in the range of 10 to 60psi preferably 20 to 40psi.
23.A process as claimed in claim 1 step vii and claim 13 wherein the deamination reaction is effected via the diazonium salt derived from a compound of formula XIV which is decomposed in the presence of alcohol or hypophosphorous acid to give directly the compound of the formula I.
24. A process as claimed in claim 1 step viii and claim 14 wherein the compound of the formula XIV is decomposed in the presence of copper (I) halide to give the halo derivative of the formula XV.
25. A process as claimed in claim 1 step viii & claim 14 wherein the diazonium salt is prepared using dil H2SO4 medium for its direct conversion to a compound of the formula I or in dil aq HX where X represents Cl or Br medium for its conversion to a compound of the formula XV.
26. A process as claimed in claim 25 wherein the decomposition temperature employed is in the range of 5 to 80° C preferably 15 to 30° C
for direct conversion to the compound of the formula I and in the range of 20 to 40° C for the conversion of the halo derivative of the formula XV.
27. A process as claimed in claim 26 wherein the halo derivative of the formula XV is dehalogenated to give the compound of the formula I by treating with Raney nickel or Pd/C under hydrogen atmosphere in the presence of acid scavenger to neutralise the liberalised acid.
28.A process as claimed in claim 27 wherein the catalyst employed for the conversion is preferably 5% Pd/C, the acid scavenger employed is amines of the general formula R3N where R represents C1 to C6 alkyl, or carbonate or bicarbonate salts of Na or K, preferably triethylamine.
29. A process as claimed in claims 27 & 28 wherein the temperature employed is in the range of 20 to 100° C preferably 20 to 40° C, the hydrogen pressure employed is in the range of 10 to 60psi preferably 20 to 40 psi., the solvent medium employed is selected from methanol, ethanol propanol, isoporpanol etc.
30. An improved process for the preparation of compound of the formula I as defined above substantially as herein described with reference to the Examples.
CA002415040A 2000-05-09 2001-03-19 An improved process for the preparation of quinolone derivatives Abandoned CA2415040A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN360/MAS/2000 2000-05-09
IN360MA2000 2000-05-09
PCT/IN2001/000042 WO2001085692A2 (en) 2000-05-09 2001-03-19 An improved process for the preparation of quinolone derivatives

Publications (1)

Publication Number Publication Date
CA2415040A1 true CA2415040A1 (en) 2001-11-15

Family

ID=11097171

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002415040A Abandoned CA2415040A1 (en) 2000-05-09 2001-03-19 An improved process for the preparation of quinolone derivatives

Country Status (1)

Country Link
CA (1) CA2415040A1 (en)

Similar Documents

Publication Publication Date Title
JP2005535612A (en) Production process of quinoline derivatives
US2811555A (en) Reduction of 2-nitroso-5-diethylaminotoluene
McKay The Preparation of N-Substituted-N1-nitroguanidines by the Reaction of Primary Amines with N-Alkyl-N-nitroso-N1-nitroguanidines
CN111808034A (en) Method for synthesizing 1,2, 4-triazole-3-methyl carboxylate
JP2011503053A (en) Process for producing 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and salts thereof
AU2002226359B2 (en) A process for the preparation of n,n'-substituted 5-amino-1,3-benzenedicarboxamides
JPH0570443A (en) Process for producing 2-(2',4'-dihydroxyphenyl)-4,6- diaryl-s-triazine
WO2001085692A2 (en) An improved process for the preparation of quinolone derivatives
CA2415040A1 (en) An improved process for the preparation of quinolone derivatives
JPH02215750A (en) Preparation of 2,6-dichlorophenylaminobenzeneacetic acid derivative
JPS6016411B2 (en) Process for the preparation of pure substituted 2,5-diarylamino terephthalic acid esters and the corresponding free acids
US5466808A (en) 8-sulfo-3-quinoline carboxylic acids and process therefore
US3390172A (en) Nu-(3-trifluoromethylphenyl)-anthranilic acids
KR20010079690A (en) Process for the preparation of substituted amido phthalocyanine derivatives and substituted amido phthalocyanine derivatives
JPH01313457A (en) Production of n-(3', 4'-dimethoxy-cinnamoyl)- anthranylic acid
JPH0258253B2 (en)
Kraska et al. Synthesis of amides of 3-hydroxy-2-naphthoic acid: derivatives of benzimidazolone and benzoxazolone
EP0415585A1 (en) Fluorobenzene derivatives
US3254125A (en) Preparation of aminodiphenyl sulfides
CA1326026C (en) Optically active benzoquinolizine compounds, process for preparing same, and antibacterial preparation containing same as active ingredient
JPH072742A (en) New production method of 4-amino-3-methyl-n-ethyl-n-(beta-hydroxyethyl)aniline sulfuric acid salt
EP0430847A1 (en) Procedure for the preparation of N-cyclopropyl-4-fluoroanilines
JPH04270272A (en) Production of aminoalkylmorpholine derivative
US4847405A (en) Method for the preparation of anilinofumarate [quinoline-2,3- dicarboxylic]
JPS6317850A (en) Production of 3-phenoxycatechols

Legal Events

Date Code Title Description
FZDE Discontinued